Chemours (CC) director Alister Cowan acquires 13,000 common shares in open market
Rhea-AI Filing Summary
Chemours Co director Alister Cowan purchased 13,000 shares of Chemours common stock on August 7, 2026 in an open-market transaction at a weighted average price of $15.62 per share, with individual trade prices ranging from $15.58 to $15.62. Following this purchase, Cowan’s directly owned holdings, including restricted stock units and dividend equivalent units, total 56,988.0387 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 13,000 shares
Net Buy
1 txn
Insider
Cowan Alister
Role
Director
Bought
13,000 shs ($203K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1, F2 | 13,000 | $15.62 | $203K |
Holdings After Transaction:
Common Stock — 56,988.0387 shares (Direct)
Footnotes (2)
- F1. The price reported is a weighted average price. These shares were purchased in multiple transactions at per share prices ranging from $15.58 to $15.62. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F2. Includes directly owned shares, restricted stock units and dividend equivalent units.
Key Figures
Shares Purchased: 13,000 shares
Weighted Average Price: $15.62 per share
Trade Price Range: $15.58–$15.62 per share
+2 more
5 metrics
Shares Purchased
13,000 shares
Common stock acquired on August 7, 2026
Weighted Average Price
$15.62 per share
Open-market purchase price for 13,000 shares
Trade Price Range
$15.58–$15.62 per share
Prices of individual trades within the reported purchase
Holdings After Transaction
56,988.0387 shares
Direct holdings including RSUs and dividend equivalent units
Net Buy Shares
13,000 shares
Net share change across all reported transactions in this filing
Key Terms
weighted average price, restricted stock units, dividend equivalent units
3 terms
weighted average price financial
"The price reported is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
restricted stock units financial
"Includes directly owned shares, restricted stock units and dividend equivalent units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend equivalent units financial
"Includes directly owned shares, restricted stock units and dividend equivalent units."
Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Chemours (CC) director Alister Cowan report in this Form 4?
Alister Cowan reported purchasing 13,000 shares of Chemours common stock on August 7, 2026. The transaction was an open-market purchase, increasing his directly owned holdings (including RSUs and dividend equivalent units) to 56,988.0387 shares after the trade.
Was the Chemours (CC) insider trade by Alister Cowan under a Rule 10b5-1 plan?
The filing does not indicate that the transaction was made under a Rule 10b5-1 trading plan. The document-level Rule 10b5-1 checkbox is marked false, and no footnote states that this purchase was pursuant to a pre-arranged plan.
What type of security did Alister Cowan acquire in Chemours (CC)?
Cowan acquired common stock of Chemours. The reported 13,000-share transaction is categorized as a non-derivative acquisition, separate from his existing restricted stock units and dividend equivalent units that are included in his total reported holdings.